Mireia Gausachs - Concepedia

Author

Mireia Gausachs

Institut Català d'Oncologia ORCID

Also Known As

Jess Del Valle, M. Gausachs, Mireia Gausachs

Publications

362

Citations

H-Index

Concepts

All Affiliations

Institut Català d'Oncologia Institut d'Investigació Biomédica de Bellvitge Bellvitge University Hospital Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública Institute of Predictive and Personalized Medicine of Cancer

About

Mireia Gausachs is an author at Institut Català d'Oncologia specializing in medicine, cancer research, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	203
2	Health Sciences	1	1	17
3	Natural Sciences	1	1	84
4	Public Health	1	1	16
5	Cell Biology	1	1	84

Mireia Gausachs

Publications

348

Citations

H-Index

Page 1

	Year	Citations
MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study Mireia Gausachs, Pilar Mur, Julieta Corral, European Journal of Human Genetics Mlh1 Promoter HypermethylationGenetic DisorderMedicineGeneticsAnalytical Algorithm	2012	86
The<i>ADAMTS12</i>metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer Ángela Moncada-Pazos, Álvaro J. Obaya, Mario F. Fraga, Journal of Cell Science Adamts12 PromoterImmunologyMolecular BiologyTumor CellsAdamts-12 Metalloprotease	2009	84
Nanofluidic Digital PCR for KRAS Mutation Detection and Quantification in Gastrointestinal Cancer Daniel Azuara, Mireia Gausachs, Francisco Rodríguez‐Moranta, Clinical Chemistry	2012	62
Benchmarking of Whole Exome Sequencing and Ad Hoc Designed Panels for Genetic Testing of Hereditary Cancer Lídia Feliubadaló, Raúl Tonda, Mireia Gausachs, Scientific Reports	2017	50
Mutational Heterogeneity in <i>APC</i> and <i>KRAS</i> Arises at the Crypt Level and Leads to Polyclonality in Early Colorectal Tumorigenesis Mireia Gausachs, Ester Borràs, Kyle Chang, Clinical Cancer Research	2017	33
Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma Elisabet Aliagas, Ania Alay, María Martínez‐Iniesta, British Journal of Cancer OncologyMalignant Pleural MesotheliomaMalignant DiseasePreclinical ModelsMedicine	2021	17
Comprehensive analysis and ACMG‐based classification of <i>CHEK2</i> variants in hereditary cancer patients Gardenia Vargas‐Parra, Jesús Del Valle, Paula Rofes, Human Mutation Breast OncologyCancer PathologyAcmg‐based ClassificationGeneticsChek2 Null Variants	2020	16

Page 1